Geode Capital Management’s Abiomed Inc ABMD Stock Holding History

Geode Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,025,568	Closed	-$252M	–	4970
2022 Q3	$252M	Buy	1,025,568 +23,477	+2%	+$6.34M	0.04%	432
2022 Q2	$248M	Buy	1,002,091 +23,517	+2%	+$6.35M	0.04%	448
2022 Q1	$323M	Buy	978,574 +24,715	+3%	+$7.61M	0.04%	408
2021 Q4	$342M	Buy	953,859 +125,325	+15%	+$42.3M	0.04%	418
2021 Q3	$269M	Buy	828,534 +35,722	+5%	+$12.1M	0.04%	453
2021 Q2	$247M	Buy	792,812 +16,151	+2%	+$4.95M	0.03%	467
2021 Q1	$247M	Sell	776,661 -3,184	-0.4%	-$1.02M	0.04%	442
2020 Q4	$252M	Buy	779,845 +36,691	+5%	+$10.1M	0.04%	402
2020 Q3	$205M	Buy	743,154 +5,376	+0.7%	+$1.55M	0.04%	397
2020 Q2	$178M	Buy	737,778 +9,735	+1%	+$1.95M	0.04%	409
2020 Q1	$105M	Buy	728,043 +18,160	+3%	+$3.01M	0.03%	486
2019 Q4	$121M	Buy	709,883 +28,943	+4%	+$5.37M	0.03%	547
2019 Q3	$121M	Buy	680,940 +23,261	+4%	+$5.03M	0.03%	510
2019 Q2	$171M	Buy	657,679 +28,434	+5%	+$7.54M	0.04%	409
2019 Q1	$179M	Buy	629,245 +22,397	+4%	+$7.44M	0.05%	378
2018 Q4	$197M	Buy	606,848 +32,418	+6%	+$11.3M	0.06%	309
2018 Q3	$258M	Buy	574,430 +62,701	+12%	+$24.7M	0.07%	266
2018 Q2	$209M	Buy	511,729 +134,333	+36%	+$48.7M	0.06%	296
2018 Q1	$110M	Buy	377,396 +16,889	+5%	+$4.28M	0.04%	479
2017 Q4	$67.6M	Buy	360,507 +10,862	+3%	+$2.03M	0.02%	588
2017 Q3	$59M	Buy	349,645 +14,176	+4%	+$2.14M	0.02%	608
2017 Q2	$48.1M	Buy	335,469 +16,461	+5%	+$2.21M	0.02%	670
2017 Q1	$39.9M	Buy	319,008 +27,061	+9%	+$3.14M	0.02%	737
2016 Q4	$32.9M	Buy	291,947 +10,931	+4%	+$1.27M	0.02%	775
2016 Q3	$36.1M	Sell	281,016 -8,437	-3%	-$1.01M	0.02%	685
2016 Q2	$31.6M	Buy	289,453 +5,912	+2%	+$588K	0.02%	704
2016 Q1	$26.9K	Buy	283,541 +6,626	+2%	+$559K	0.01%	763
2015 Q4	$25M	Buy	276,915 +17,402	+7%	+$1.48M	0.01%	776
2015 Q3	$24.1M	Buy	259,513 +22,711	+10%	+$2M	0.01%	780
2015 Q2	$15.6M	Buy	236,802 +11,126	+5%	+$739K	0.01%	1098
2015 Q1	$16.2M	Buy	225,676 +14,600	+7%	+$792K	0.01%	1050
2014 Q4	$8.03M	Buy	211,076 +12,567	+6%	+$396K	﹤0.01%	1510
2014 Q3	$4.93M	Buy	198,509 +2,153	+1%	+$54.5K	﹤0.01%	1779
2014 Q2	$4.94M	Buy	196,356 +2,010	+1%	+$46.8K	﹤0.01%	1803
2014 Q1	$5.06M	Buy	194,346 +14,625	+8%	+$405K	﹤0.01%	1760
2013 Q4	$4.8M	Buy	179,721 +18,398	+11%	+$455K	﹤0.01%	1740
2013 Q3	$3.08M	Buy	161,323 +5,391	+3%	+$123K	﹤0.01%	1917
2013 Q2	$3.36M	Buy	+155,932	New	+$3.13M	﹤0.01%	1697

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geode Capital Management's ABMD Position: Q4 2022 in Review

Geode Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,025,568 shares — an estimated $252M sold.

Geode Capital Management first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $342M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Geode Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Geode Capital Management sold 1,025,568 Abiomed Inc shares in Q4 2022, an estimated $252M.
Geode Capital Management first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Geode Capital Management's Abiomed Inc position peaked at $342M in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.